Want to see NVZMY full AI Analyst Report?
Novonesis (NVZMY) Financial Statements
Novonesis Financial Overview
Novonesis's market cap is currently $32.16B. The company's EPS TTM is $1.39; its P/E ratio is 44.16; and it has a dividend yield of 0.23%. Novonesis is estimated to report earnings on November 5, 2026, and the estimated EPS forecast is $0.76. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 4.16B | $ 513.65M | $ 17.90B | $ 17.55B | $ 14.95B |
| Gross Profit | $ 2.24B | $ 242.45M | $ 9.72B | $ 9.58B | $ 8.62B |
| Operating Income | $ 882.60M | $ 663.73M | $ 3.98B | $ 4.56B | $ 4.07B |
| EBITDA | $ 1.39B | $ 1.21B | $ 5.47B | $ 6.12B | $ 5.39B |
| Net Income | $ 583.60M | $ 40.97M | $ 3.02B | $ 3.68B | $ 3.15B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 295.60M | $ 284.00M | $ 1.16B | $ 1.11B | $ 1.04B |
| Total Assets | $ 16.35B | $ 15.20B | $ 28.39B | $ 27.98B | $ 24.77B |
| Total Debt | $ 22.45B | $ 1.80B | $ 7.73B | $ 6.95B | $ 482.00M |
| Net Debt | $ 22.17B | $ 1.52B | $ 6.62B | $ -630.00M | $ -481.00M |
| Total Liabilities | $ 5.49B | $ 4.02B | $ 14.04B | $ 13.76B | $ 12.56B |
| Stockholders' Equity | $ 10.86B | $ 11.18B | $ 13.98B | $ 13.84B | $ 11.83B |
| Cash Flow | |||||
| Free Cash Flow | $ 750.70M | $ 660.10M | $ 2.10B | $ 1.12B | $ 2.82B |
| Operating Cash Flow | $ 1.22B | $ 1.02B | $ 4.15B | $ 4.01B | $ 4.06B |
| Investing Cash Flow | $ -1.97B | $ -199.70M | $ -2.13B | $ -2.67B | $ -2.75B |
| Financing Cash Flow | $ 753.30M | $ -703.20M | $ -1.89B | $ -1.25B | $ -1.59B |
Currency in DKK